JP2010514758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010514758A5 JP2010514758A5 JP2009543946A JP2009543946A JP2010514758A5 JP 2010514758 A5 JP2010514758 A5 JP 2010514758A5 JP 2009543946 A JP2009543946 A JP 2009543946A JP 2009543946 A JP2009543946 A JP 2009543946A JP 2010514758 A5 JP2010514758 A5 JP 2010514758A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- substituted
- dihydroxy
- formula
- pyran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C*([n]1nnc(SS=*)c1)=C Chemical compound C*([n]1nnc(SS=*)c1)=C 0.000 description 4
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020060139200A KR100868959B1 (ko) | 2006-12-30 | 2006-12-30 | 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는면역보조용 약학적 조성물 |
| KR10-2006-0139200 | 2006-12-30 | ||
| PCT/KR2007/006889 WO2008082156A1 (en) | 2006-12-30 | 2007-12-27 | Alpha-galactosylceramide derivatives, pharmaceutically acceptable salts thereof, preparation method and pharmaceutical composition for the immune adjuvant containing the same as an active ingredient |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010514758A JP2010514758A (ja) | 2010-05-06 |
| JP2010514758A5 true JP2010514758A5 (enExample) | 2012-08-02 |
| JP5167273B2 JP5167273B2 (ja) | 2013-03-21 |
Family
ID=39588766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009543946A Active JP5167273B2 (ja) | 2006-12-30 | 2007-12-27 | αガラクトシルセラミド誘導体、その薬学的に許容可能な塩、その製造方法及びそれを有効成分として含む免疫補助用薬学的組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8883746B2 (enExample) |
| EP (1) | EP2102225A4 (enExample) |
| JP (1) | JP5167273B2 (enExample) |
| KR (1) | KR100868959B1 (enExample) |
| CN (2) | CN102816189B (enExample) |
| WO (1) | WO2008082156A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8916164B2 (en) | 2007-08-29 | 2014-12-23 | Abivax | Methods of enhancing adjuvaticity of vaccine compositions |
| BRPI0820960B8 (pt) | 2007-12-05 | 2021-05-25 | Abivax | composição, composição farmacêutica, e uso da composição |
| US7928077B2 (en) * | 2008-07-11 | 2011-04-19 | Academia Sinica | Alpha-galactosyl ceramide analogs and their use as immunotherapies |
| US9220767B2 (en) | 2008-10-08 | 2015-12-29 | Abivax | Vaccine composition for use against influenza |
| KR20110045545A (ko) * | 2009-10-27 | 2011-05-04 | 서울대학교산학협력단 | 신규 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 면역보조용 약학적 조성물 |
| EP2532671B1 (en) | 2010-02-05 | 2014-09-17 | Riken | Novel synthetic glycolipid and use thereof |
| JP6057300B2 (ja) * | 2011-01-05 | 2017-01-11 | ナショナル タイワン ユニバーシティ | グリコスフィンゴ脂質の調製及びその使用の方法 |
| KR101307331B1 (ko) * | 2012-02-01 | 2013-09-10 | 서울대학교산학협력단 | 신규 알파-갈락토실세라마이드 유도체, 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 면역보조용 약학적 조성물 |
| WO2013119857A1 (en) | 2012-02-07 | 2013-08-15 | The Regents Of The University Of California | Glycosphingolipids for use in modulating immune responses |
| US9464105B2 (en) | 2012-08-03 | 2016-10-11 | Riken | Hydroxylated KRN7000 analogue and use thereof |
| KR101969129B1 (ko) * | 2012-08-03 | 2019-04-15 | (주)스파크바이오파마 | 알파-갈락토실세라마이드 유사체, 이의 제조방법 및 이를 포함하는 면역조절 이상으로 인한 질환의 치료 또는 예방용 약학적 조성물 |
| EP2903622A1 (en) | 2012-10-03 | 2015-08-12 | INSERM - Institut National de la Santé et de la Recherche Médicale | Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists |
| EP2906576B1 (en) | 2012-10-12 | 2019-09-11 | The Brigham and Women's Hospital, Inc. | Glycosphingolipids and methods of use thereof |
| EP3434684A4 (en) | 2016-03-22 | 2019-11-27 | Keio University | COMPOUND OR SALT THEREOF, NATURAL KILLER T CELL ACTIVATOR AND PHARMACEUTICAL COMPOSITION |
| WO2017207040A1 (en) | 2016-06-01 | 2017-12-07 | Vib Vzw | ANTI-CANCER THERAPY USING A LEPTIN ANTAGONIST AND AN iNKT-CELL ACTIVATOR |
| EP4174074A1 (en) | 2021-10-29 | 2023-05-03 | Consejo Superior de Investigaciones Científicas (CSIC) | Multiantennary glycolipid mimetics |
| CN115286667B (zh) * | 2022-08-02 | 2024-03-26 | 华中农业大学 | 一种α-半乳糖基神经酰胺类似物及其制备方法和应用 |
| WO2025035125A1 (en) * | 2023-08-10 | 2025-02-13 | The Curators Of The University Of Missouri | Suppression of type 1 diabetes by intrathymic il-4 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61502124A (ja) * | 1984-05-09 | 1986-09-25 | ジ オ−ストラリアン ナシヨナル ユニヴア−シテイ− | 免疫応答の調節方法 |
| US5936076A (en) * | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
| JPH0559081A (ja) * | 1991-08-29 | 1993-03-09 | Kirin Brewery Co Ltd | 新規スフインゴ糖脂質、その製造法および使用 |
| EP1520583B1 (en) | 1997-04-10 | 2009-01-28 | Kyowa Hakko Kirin Co., Ltd. | NKT cell-activating agents containing alpha-glycosylceramides |
| AU2002327097B2 (en) * | 2001-08-16 | 2007-05-24 | Japan As Represented By President Of National Centre Of Neurology And Psychiatry | Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient |
| WO2003105769A2 (en) * | 2002-06-13 | 2003-12-24 | New York University | Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases |
| AU2005280163B2 (en) * | 2004-08-27 | 2011-11-24 | Albert Einstein College Of Medicine, Inc. | Ceramide derivatives as modulators of immunity and autoimmunity |
-
2006
- 2006-12-30 KR KR1020060139200A patent/KR100868959B1/ko not_active Expired - Fee Related
-
2007
- 2007-12-27 CN CN201210275308.8A patent/CN102816189B/zh active Active
- 2007-12-27 EP EP07851806A patent/EP2102225A4/en not_active Withdrawn
- 2007-12-27 WO PCT/KR2007/006889 patent/WO2008082156A1/en not_active Ceased
- 2007-12-27 CN CNA2007800486889A patent/CN101573369A/zh active Pending
- 2007-12-27 JP JP2009543946A patent/JP5167273B2/ja active Active
- 2007-12-27 US US12/521,487 patent/US8883746B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2609987T3 (es) | Piridinonas bicíclicas novedosas | |
| US20240374595A1 (en) | Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same | |
| JP2021534124A5 (enExample) | ||
| US9334268B2 (en) | 4-amino-imidazoquinoline compounds | |
| CN1063942C (zh) | 一种噻唑烷衍生物的制药应用 | |
| US10597390B2 (en) | Indoles for use in influenza virus infection | |
| JP5008778B2 (ja) | 新規５−フルオロウラシル誘導体 | |
| TW200927123A (en) | Novel compounds | |
| JP2014504593A5 (enExample) | ||
| US20110288076A1 (en) | Sphingosine-1-Phosphate Receptor Antagonists | |
| JP2002520316A5 (enExample) | ||
| JP2010514758A (ja) | αガラクトシルセラミド誘導体、その薬学的に許容可能な塩、その製造方法及びそれを有効成分として含む免疫補助用薬学的組成物 | |
| JP2017523214A (ja) | ヘテロ環キナーゼ阻害剤 | |
| JP2009040767A5 (enExample) | ||
| JP2019524797A5 (enExample) | ||
| TW201319036A (zh) | 苯基衍生物 | |
| US9676727B2 (en) | Myxovirus therapeutics, compounds, and uses related thereto | |
| CA2589744A1 (en) | Pyrrolinidium derivatives as m3 muscarinic receptors | |
| US8987459B2 (en) | Compounds for the treatment of conditions associated with DGAT1 activity | |
| US11453657B2 (en) | Compounds for the treatment of parasitic infections | |
| KR20070000508A (ko) | 화학적 방법 및 결정형 | |
| KR20250003436A (ko) | 오각고리 염기를 포함하는 비고리형 핵산 모방체 | |
| JP6219817B2 (ja) | フェニルキサンテン誘導体 | |
| JP2008521874A5 (enExample) | ||
| CN107207407A (zh) | 用于治疗疾病和病症的组合物和方法 |